Home / Business and Economy / Carlyle Eyes IPO for India Healthcare Unit
Carlyle Eyes IPO for India Healthcare Unit
3 Jul
Summary
- Carlyle Group is exploring an IPO for its Indian healthcare business.
- The firm has appointed JM Financial and Goldman Sachs as advisors.
- The potential IPO could raise as much as $400 million.
Carlyle Group Inc. is reportedly exploring the possibility of an initial public offering (IPO) for its Indian healthcare revenue cycle management division. To facilitate this potential offering, the private equity firm has engaged the services of JM Financial Ltd. and Goldman Sachs Group Inc.
Sources close to the matter indicate that Carlyle is contemplating raising a substantial amount, potentially as much as $400 million, through this IPO. This strategic move underscores the firm's interest in expanding its presence within India's growing healthcare sector.
The company's healthcare revenue cycle management business is poised to be the focus of this public offering. The involvement of prominent financial institutions like JM Financial and Goldman Sachs suggests a serious consideration of the IPO route.
This development comes as Carlyle Group continues to assess various investment and divestment strategies across its portfolio. The potential IPO aims to leverage the market's appetite for healthcare-related assets in India.
